BioPortUSA announced today that they have started work with French based Fizimed. “We are excited to be working with Fizimed, our first women founded and women owned life sciences client” said Mark Lesselroth, CEO of Bioport. Emeline Hahn, founder of Fizimed has developed a truly innovative product that addresses a major problem in women’s health. Her product called Emy is a wireless kegel trainer that helps stop urinary leaks.
BioPort’s first assignment is to identify the best regulatory path forward. In anticipation that there won’t be any issues with getting this product registered with the FDA, BioPort is already looking at what makes the most sense to help them commercialize Emy in the U.S.A.
The Emy device is the solution for pelvic floor training for all women that suffer from urinary leaks in their daily life, this condition effects 10% of women worldwide. Emy measures perineal strength, tracks contractions and your progress. After 2 years of medical research, Emy was designed based on the ergonmics used by health professionals. Its soft and unique shape accomodates all users.